mephentermine has been researched along with Coronary Disease in 2 studies
Mephentermine: A sympathomimetic agent with specificity for alpha-1 adrenergic receptors. It is used to maintain BLOOD PRESSURE in hypotensive states such as following SPINAL ANESTHESIA.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moret, PR | 1 |
| Megevand, R | 1 |
| Gemperle, M | 1 |
| Cooper, RW | 1 |
| Ritota, MC | 1 |
| Vincelette, RB | 1 |
2 other studies available for mephentermine and Coronary Disease
| Article | Year |
|---|---|
[Action of various vasoactive amines on the normal and pathological cardiac function, mainly cardiogenic shock].
Topics: Angiotensin II; Animals; Coronary Disease; Dogs; Electrocardiography; Epinephrine; Heart; Heart Rate | 1966 |
The pharmacologic radiocardiogram in health and disease.
Topics: Adult; Cardiac Catheterization; Coronary Disease; Coronary Vessels; Dipyridamole; Estrogens; Exercis | 1968 |